Latest Articles
Study Identifies E2F8 as Key Regulator of DTL and MAPK Pathway in Endometrial Cancer Progression - geneonline.com
Study Identifies E2F8 as Key Regulator of DTL and MAPK Pathway in Endometrial Cancer Progression geneonline.com
Published: Dec. 30, 2025, 4:33 a.m.
E2F8 Boosts DTL, Driving Endometrial Cancer via MAPK - Bioengineer.org
E2F8 Boosts DTL, Driving Endometrial Cancer via MAPK Bioengineer.org
Published: Dec. 30, 2025, 3:47 a.m.
E2F8 Boosts DTL, Driving Endometrial Cancer via MAPK - BIOENGINEER.ORG
E2F8 Boosts DTL, Driving Endometrial Cancer via MAPK BIOENGINEER.ORG
Published: Dec. 30, 2025, 3:47 a.m.
Taurine alleviates oxidative stress, inflammation, and mitochondrial apoptosis in lipopolysaccharide-induced bovine endometrial epithelial cells by activating Nrf2/HO-1 and inhibiting TLR4-MAPK/NF-κB and Caspase-3 pathways - ScienceDirect.com
Taurine alleviates oxidative stress, inflammation, and mitochondrial apoptosis in lipopolysaccharide-induced bovine endometrial epithelial cells by activating Nrf2/HO-1 and inhibiting TLR4-MAPK/NF-κB and Caspase-3 pathways ScienceDirect.com
Published: July 22, 2025, 5:55 p.m.
Combinations Targeting PI3K/ AKT/mTOR and MAPK/ERK Pathways Are Under Study in Endometrial Cancer - OncLive
Combinations Targeting PI3K/ AKT/mTOR and MAPK/ERK Pathways Are Under Study in Endometrial Cancer OncLive
Published: May 21, 2025, 2:09 p.m.
Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer - Nature.com
Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer Nature.com
Published: Feb. 8, 2025, 1:17 p.m.
GnRH-mediated suppression of S100A4 expression inhibits endometrial epithelial cell proliferation in sheep via GNAI2/MAPK signaling - Frontiers
GnRH-mediated suppression of S100A4 expression inhibits endometrial epithelial cell proliferation in sheep via GNAI2/MAPK signaling Frontiers
Published: May 29, 2024, 7 a.m.
Link copied to clipboard!